| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,§,§
*
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115;
Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Molecular Medicine, Department of Medicine, The Children’s Hospital, Howard Hughes Medical Institute, Boston, MA 02115;
§
Department of Molecular and Cellular Biology, Harvard University, Howard Hughes Medical Institute, Cambridge, MA 02138;
¶
Structural Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; and
||
Instiut de Recherches Cliniques de Montréal, Laboratoire d’Immunologie, Montreal, Quebec, Canada
The crystal structures of two human TCRs specific for a HTLV-I Tax peptide bound to HLA-A2 were recently determined, for the first time allowing a functional comparison of TCRs for which the MHC/peptide/TCR structures are known. Extensive amino acid substitutions show that the native Tax residues are optimal at each peptide position. A prominent feature of the TCR contact surface is a deep pocket that accommodates a tyrosine at position 5 of the peptide. For one of these TCRs, this pocket is highly specific for aromatic residues. In the other TCR structure, this pocket is larger, allowing many different residues to be accommodated. The CTL clones also show major differences in the specificity for several other peptide residues, including side chains that are not directly contacted by the TCR. Despite the specificity of these clones, peptides that are distinct at five or six positions from Tax11–19 induce CTL activity, indicating that substantial changes of the peptide surface are tolerated. Human peptides with limited sequence homology to Tax11–19 represent partial TCR agonists for these CTL clones. The distinct functional properties of these CTL clones highlight structural features that determine TCR specificity and cross-reactivity for MHC-bound peptides.
This article has been cited by other articles:
|
|
 |
|
  Y. N. Naumov, E. N. Naumova, M. B. Yassai, K. Kota, R. M. Welsh, and L. K. Selin Multiple Glycines in TCR {alpha}-Chains Determine Clonally Diverse Nature of Human T Cell Memory to Influenza A Virus J. Immunol., November 15, 2008; 181(10): 7407 - 7419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Purbhoo, D. H. Sutton, J. E. Brewer, R. E. Mullings, M. E. Hill, T. M. Mahon, J. Karbach, E. Jager, B. J. Cameron, N. Lissin, et al. Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. J. Immunol., June 15, 2006; 176(12): 7308 - 7316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al. Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Lee, G. Stewart-Jones, T. Dong, K. Harlos, K. Di Gleria, L. Dorrell, D. C. Douek, P. A. van der Merwe, E. Y. Jones, and A. J. McMichael T Cell Cross-Reactivity and Conformational Changes during TCR Engagement J. Exp. Med., December 6, 2004; 200(11): 1455 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Baxter, S. J. Gagnon, R. L. Davis-Harrison, J. C. Beck, A.-K. Binz, R. V. Turner, W. E. Biddison, and B. M. Baker Strategic Mutations in the Class I Major Histocompatibility Complex HLA-A2 Independently Affect Both Peptide Binding and T Cell Receptor Recognition J. Biol. Chem., July 9, 2004; 279(28): 29175 - 29184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. M. Bangham The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 J. Gen. Virol., December 1, 2003; 84(12): 3177 - 3189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Biddison, R. V. Turner, S. J. Gagnon, A. Lev, C. J. Cohen, and Y. Reiter Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes J. Immunol., September 15, 2003; 171(6): 3064 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tzagarakis-Foster, R. Geleziunas, A. Lomri, J. An, and D. C. Leitman Estradiol Represses Human T-cell Leukemia Virus Type 1 Tax Activation of Tumor Necrosis Factor-alpha Gene Transcription J. Biol. Chem., November 15, 2002; 277(47): 44772 - 44777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Castilleja, D. Carter, C. L. Efferson, N. E. Ward, K. Kawano, B. Fisk, A. P. Kudelka, D. M. Gershenson, J. L. Murray, C. A. O'Brian, et al. Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex J. Immunol., October 1, 2002; 169(7): 3545 - 3554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hernandez, F. Garcia-Pons, Y. C. Lone, H. Firat, J. D. Schmidt, P. Langlade-Demoyen, and M. Zanetti Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells PNAS, September 17, 2002; 99(19): 12275 - 12280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, R. Turner, B. M. Baker, and W. E. Biddison MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors J. Immunol., September 15, 2002; 169(6): 3146 - 3154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Bourcier, D.-G. Lim, Y.-H. Ding, K. J. Smith, K. Wucherpfennig, and D. A. Hafler Conserved CDR3 Regions in T-Cell Receptor (TCR) CD8+ T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure J. Virol., October 15, 2001; 75(20): 9836 - 9843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Karanikas, D. Colau, J.-F. Baurain, R. Chiari, J. Thonnard, I. Gutierrez-Roelens, C. Goffinet, E. V. Schaftingen, P. Weynants, T. Boon, et al. High Frequency of Cytolytic T Lymphocytes Directed against a Tumor-specific Mutated Antigen Detectable with HLA Tetramers in the Blood of a Lung Carcinoma Patient with Long Survival Cancer Res., May 1, 2001; 61(9): 3718 - 3724. [Abstract] [Full Text]
|
|
|
|
|
|
B. M. Baker, R. V. Turner, S. J. Gagnon, D. C. Wiley, and W. E. Biddison Identification of a Crucial Energetic Footprint on the {{alpha}}1 Helix of Human Histocompatibility Leukocyte Antigen (HLA)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/HLA-A2-specific T Cell Receptors J. Exp. Med., February 26, 2001; 193(5): 551 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kraj, R. Pacholczyk, and L. Ignatowicz {{alpha}}{{beta}}TCRs Differ in the Degree of Their Specificity for the Positively Selecting MHC/Peptide Ligand J. Immunol., February 15, 2001; 166(4): 2251 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Peydro, A. Paradela, J. P. Albar, and J. A. L. d. Castro Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope J. Immunol., November 15, 2000; 165(10): 5680 - 5685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trop, J. Charron, C. Arguin, and P. Hugo Thymic Selection Generates T Cells Expressing Self-Reactive TCRs in the Absence of CD45 J. Immunol., September 15, 2000; 165(6): 3073 - 3079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wienhold, G. Malcherek, C. Jung, S. Stevanovic, G. Jung, H. Schild, and A. Melms An example of immunodominance: engagement of synonymous TCR by invariant CDR3{beta} Int. Immunol., June 1, 2000; 12(6): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.M. BAKER, Y.-H. DING, D.N. GARBOCZI, W.E. BIDDISON, and D.C. WILEY Structural, Biochemical, and Biophysical Studies of HLA-A2/Altered Peptide Ligands Binding to Viral-peptide-specific Human T-cell Receptors Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 235 - 242. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
